Prl Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 14-12-2024
- Paid Up Capital ₹ 0.33 M
as on 14-12-2024
- Company Age 1 Year 9 Months
- Last Filing with ROC 31 Mar 2024
About Prl Diagnostics
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.33 M, as per Ministry of Corporate Affairs (MCA) records.
Surajit Chakrabartty, Suryaprakasam Ramprasad, Mayank Madan, and Two other members serve as directors at the Company.
- CIN/LLPIN
U86905DL2023PTC410679
- Company No.
410679
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Mar 2023
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Prl Diagnostics?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surajit Chakrabartty  | Director | 26-Jun-2023 | Current |
| Suryaprakasam Ramprasad | Director | 10-Apr-2024 | Current |
| Mayank Madan | Director | 03-Mar-2023 | Current |
| Deepak Sadwani | Director | 03-Mar-2023 | Current |
| Smita Sadwani | Director | 03-Mar-2023 | Current |
Financial Performance and Corporate Structure Insights of Prl Diagnostics.
Enhance accessibility to Prl Diagnostics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Prl Diagnostics?
Unlock access to Prl Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Immucare Diagnostics Private LimitedActive 5 years 8 monthsSurajit Chakrabartty and Suryaprakasam Ramprasad are mutual person
Trident Diagnostics & Healthcare Private LimitedActive 8 years 5 monthsSurajit Chakrabartty and Suryaprakasam Ramprasad are mutual person
Ekavidha Corporate Services Private LimitedActive 9 years 8 monthsSurajit Chakrabartty is a mutual person
Ans Diagnostics Private LimitedActive 1 year 8 monthsSurajit Chakrabartty and Suryaprakasam Ramprasad are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Prl Diagnostics?
Unlock and access historical data on people associated with Prl Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prl Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prl Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.